Patents by Inventor Thomas Hunig

Thomas Hunig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes
    Publication number: 20060039909
    Abstract: The invention teaches human-compatible monoclonal antibodies which are specific against human CD28 and human T-lymphocytes of several to all subgroups to activate without occupancy of an antigen receptor of the human T-lymphocytes and thus antigen-non-specifically.
    Type: Application
    Filed: December 23, 2004
    Publication date: February 23, 2006
    Inventor: Thomas Hunig
  • Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes
    Patent number: 6987171
    Abstract: The invention teaches human-compatible monoclonal antibodies which are specific against human CD28 and human T-lymphocytes of several to all sub-groups to activate without occupancy of an antigen receptor of the human T-lymphocytes and thus antigen-non-specifically.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: January 17, 2006
    Assignee: Tegenero GmbH
    Inventor: Thomas Hunig
  • Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28
    Publication number: 20040247594
    Abstract: The invention teaches the use of monoclonal antibodies being specific for CD28 and activating T lymphocytes of several to all sub-groups without an occupation of an antigen receptor of the T lymphocytes and thus in an antigen-unspecific manner, or of an analogue hereto, for the preparation of a pharmaceutical composition for stimulating blood cells not carrying CD28, and for treating diseases with a reduced number of such blood cells.
    Type: Application
    Filed: July 2, 2004
    Publication date: December 9, 2004
    Inventors: Thomas Hunig, Marta Rodriguez-Palmero, Thomas Kerkau
  • Use of a CD28 binding substance for making a pharmaceutical composition
    Publication number: 20040092718
    Abstract: The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimicry compound hereto for making a pharmaceutical composition for the induction and/or multiplication of regulatory T cells.
    Type: Application
    Filed: March 13, 2003
    Publication date: May 13, 2004
    Inventor: Thomas Hunig
  • Peptide or protein containing a C '-D loop of the CD28 receptor family
    Publication number: 20030166860
    Abstract: The invention relates to a protein or peptide comprising the C′-D loop of a member of the CD28 family, uses thereof and mAbs obtainable therefrom.
    Type: Application
    Filed: December 4, 2002
    Publication date: September 4, 2003
    Inventors: Thomas Hunig, Fred Luhder, Thomas Hanke